Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients-Reference-Cited by-同舟云学术

Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients

Published:2022-07-27 Issue:1 Volume:68 Page:323-332
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Liu Yen-Chun,Cheng Ya-Ting,Chen Yi-Cheng,Hsieh Yi-Chung,Jeng Wen-Juei^ORCID,Lin Chun-Yen,Chien Rong-Nan,Tai Dar-In,Sheen I.-Shyan

Funder

Chang Gung Memorial Hospital, Linkou

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-022-07621-6.pdf

Reference30 articles.

1. European Association for The Study of The Liver. EASL recommendations on treatment of hepatitis C 2018. J Hepatol. 2018;69:461–511.

2. Ghany MG, Morgan TR. AASLD-IDSA hepatitis C guidance panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology 2020;71:686–721.

3. Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2018;68:25–32.

4. Thabut D, Bureau C, Layese R et al. Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy. Gastroenterology 2019;156:e1005.

5. McDonald SA, Pollock KG, Barclay ST et al. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis. J Viral Hepatitis 2020;27:270–280.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical review of diagnostic and prognostic markers of chronic hepatitis B infection;Medical Review;2024-05-08

2. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

3. Correction: Comparing Predictability of Non‑invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients;Digestive Diseases and Sciences;2022-10-17

4. Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR;Digestive Diseases and Sciences;2022-07-27